2024-11-03 03:40:42
FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment of Patients with Metastatic NSCLC with METex14 Skipping Alterations
Health/ 2023-07-22
FDA Accepts Filing of New Drug Applicati...

- Tepotinib granted Priority Review and is being evaluated under FDA Real-Time Oncology Review (RTOR) pilot program

AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
Corporate/ 2023-07-23
AGC Biologics Completes PPQ Manufacturin...

SEATTLE,Aug. 25,2020-- AGC Biologics,a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO),achieved ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release